Clin Mol Hepatol.
2015 Sep;21(3):200-211. 10.3350/cmh.2015.21.3.200.
Personalized management of cirrhosis by non-invasive tests of liver fibrosis
- Affiliations
-
- 1Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong. wongv@cuhk.edu.hk
- 2State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong.
- KMID: 2351019
- DOI: http://doi.org/10.3350/cmh.2015.21.3.200
Abstract
- Owing to the high prevalence of various chronic liver diseases, cirrhosis is one of the leading causes of morbidity and mortality worldwide. In recent years, the development of non-invasive tests of fibrosis allows accurate diagnosis of cirrhosis and reduces the need for liver biopsy. In this review, we discuss the application of these non-invasive tests beyond the diagnosis of cirrhosis. In particular, their role in the selection of patients for hepatocellular carcinoma surveillance and varices screening is highlighted.
